IGF1 and type 2 diabetes mellitus: Increased promoter methylation and decreased expression were seen for e.g. BEST3, HHATL and SLC2A2, while e.g. IGF1, SFRP4 and SYNPO had reduced promoter methylation and increased expression in islets from T2D donors (Supplementary Fig. 3g).